Ratan Tata invests in medtech startup Axio

2018-01-30 08:31:40

Axio Biosolutions raises $7.4mn in Series B round from Ratan Tata’s RNT Capital along with existing investors Accel Partners and IDG Ventures India. By Team ABLEAxio Biosolutions, the first Indian company to launch an emergency haemostat for trauma care, has raised $7.4 million in a Series B funding round led by Ratan Tata’s RNT Capital along with existing investors Accel Partners and IDG Vent

Read more

Biocon clocks Rs 1092 crore in Q3FY18 revenue

2018-01-29 08:14:53

In this quarter, Biocon has accomplished a major milestone of obtaining USFDA approval for biosimilar Trastuzumab partnered with Mylan; and another highlight was the new strategic partnership with SandozBy Team ABLEAsia\'s premier biopharmaceuticals company Biocon Ltd has announced its consolidated financial results for the fiscal third quarter ended on December 31st, 2017.Commenting on the highli

Read more

President launches countrywide Pulse Polio Program for 2018

2018-01-29 07:10:11

More than 17 crore children of less than five years across the country will be given polio drops as part of the drive of Government of India to sustain polio eradication from the country.By Team ABLEThe Hon. President of India, Mr Ram Nath Kovind, launched the Pulse Polio programme for 2018 by administering polio drops to children less than five years old, at the Rahstrapati Bhawan, in the presenc

Read more

India-made Bharat Biotech’s Rotavirus Vaccine secures World Health Organization’s prequalification grant

2018-01-29 05:53:50

WHO has granted prequalification to Bharat Biotech’s ROTAVAC vaccine. This vaccine is noted to be the world’s first Made-in-India rotavirus vaccine. By Team ABLEBharat Biotech has announced that the World Health Organization (WHO Geneva) has awarded prequalification to the developing world’s first rotavirus vaccine, ROTAVAC. WHO Prequalification is necessary for UN agencies and Gavi, the Vac

Read more

Prof Dinabandhu Sahoo, IBSD Director bestowed with Honoris Causa by Kalinga Institute

2018-01-29 05:52:12

The award has been granted for his scientific achievements and contributions in the field of bioresources and sustainable development.By Team ABLEProf Dinabandhu Sahoo, Director of Institute of Bioresources and Sustainable Development (IBSD), a National Institute of Department of Biotechnology, Government of India, has been conferred the Doctor of Science (D.Sc.) Honoris Causa by Kalinga Institute

Read more

Indian scientists achieve breakthrough in modifying banana genome using CRISPR

2018-01-25 21:32:57

A group of Indian researchers at the National Agri-Food Biotechnology Institute, Mohali, have used latest gene editing techniques to modify the banana genome, for the first time.By Team ABLEA group of Indian researchers at the National Agri-Food Biotechnology Institute, Mohali, have used latest gene editing techniques to modify the banana genome, for the first time.Banana is the fourth most import

Read more

Syngene International posted 10.81% increase in net profit at Rs 82 crore

2018-01-23 16:42:28

Biocon\'s contract research arm Syngene International reported 10.81 per cent increase in its net profit. Its profit stood at Rs 82 crore for the third quarter ended December 2017.The company had reported a profit of Rs 74 crore for the same period of the previous fiscal.Revenue of the company increased to Rs 399 crore for the third quarter as compared with Rs 347 crore in the same period of the p

Read more

Celgene Corporation spends $9 million to acquire Juno Therapeutics

2018-01-23 16:21:19

Juno is a pioneer in the development of CAR (chimeric antigen receptor) T and TCR (T cell receptor) therapeutics for cancer indications.By Team ABLENASDAQ-listed companies Celgene Corporation and Juno Therapeutics, have announced the signing of a definitive merger agreement in which Celgene has agreed to acquire Juno. Under the terms of the merger agreement, Celgene will pay $87 per share in cash,

Read more

Sinobioway Group invests in Canada’s Enerkem to escalate bio-fuel business

2018-01-23 16:20:08

The investment from Sinobioway is expected to accelerate the global expansion of Enerkem by introducing the latter’s waste-to-biofuels technology to the Chinese market.By Team ABLEChinese bio-industrial conglomerate, Sinobioway Group has made an equity investment of C$125m ($100.2m) in Canada-based Enerkem, a manufacturer of waste-to-biofuels and renewable chemicals.The investment from Sinobiowa

Read more

Sanofi acquires Bioverativ for $11.6 billion; strengthens market share in rare disease therapeutics

2018-01-23 16:18:35

With the acquisition of Bioverativ, Sanofi enhances its presence in specialty care and leadership in rare diseases, in line with its 2020 RoadmapBy Team ABLESanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ fo

Read more